Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ProKidney Corp.

PROK
Current price
1.7 USD -0.49 USD (-22.25%)
Last closed 2.15 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 811 826 048 USD
Yield for 12 month +37.80 %
1Y
3Y
5Y
10Y
15Y
PROK
21.11.2021 - 28.11.2021

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina. Address: 2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-3 169 000 USD

Last Year

-3 036 000 USD

Current Quarter

-964 000 USD

Last Quarter

-832 000 USD

Key Figures PROK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -149 436 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -19.57 %
PEG Ratio
Return On Equity TTM -29.6 %
Wall Street Target Price 4.67 USD
Revenue TTM
Book Value -7.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.6 USD
Diluted Eps TTM -0.6 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PROK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PROK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:1
Payout Ratio
Last Split Date 12.07.2022
Dividend Date

Stock Valuation PROK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 2.1287
Price Book MRQ 91.3172

Financials PROK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PROK

For 52 weeks

1.12 USD 4.44 USD
50 Day MA 1.97 USD
Shares Short Prior Month 10 021 794
200 Day MA 2.15 USD
Short Ratio 9.03
Shares Short 10 735 613
Short Percent 9.33 %